Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - OTHER CURRENT LIABILITIES
Other Current Liabilities AKBA - Akebia Therapeutics, Inc.
61.2 M
LAST VALUE
-23.37%
2 YEAR CAGR
-16.52%
5 YEAR CAGR
34.38%
10 YEAR CAGR